首页> 外国专利> METHOD OF TREATING INFILTRATIVE PULMONARY TUBERCULOSIS INDUCED BY MULTIPLE-DRUG-RESISTANT AND HIGHLY TOXIC STRAINS OF MYCOBACTERIA TUBERCULOSIS

METHOD OF TREATING INFILTRATIVE PULMONARY TUBERCULOSIS INDUCED BY MULTIPLE-DRUG-RESISTANT AND HIGHLY TOXIC STRAINS OF MYCOBACTERIA TUBERCULOSIS

机译:治疗多药耐药结核分枝杆菌高毒菌株所致的感染性肺结核的方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, namely to phthisiology, and can be used for treatment of infiltrative pulmonary tuberculosis (IPT), induced by multiple-drug-resistant and highly toxic strains of Mycobacteria tuberculosis (MDR MBT). In case if multiple drug resistance of Mycobacteria tuberculosis is determined, patient is administered fluoroquinolones and isoniazid intravenously, as well as prednisolone in dose 25-30 mg during 1.5 months. After that carried out is intensive therapy regimen with correction of isoniazid dose - in case of drug resistance to small concentrations, isoniazid is introduced intravenously in dose 15 mg/kg, in case of drug resistance to medium and high concentrations - in dose 20 mg/kg in two steps - intravenously and per os 0.3 g with 5-6 hour interval, in case if highly toxic properties of mycobacteria are confirmed, intensive therapy regimen is prolonged to 8-10 months.;EFFECT: application of invention makes it possible to increase efficiency of treatment of IPT induced by MDR MBT due to carrying out optimal correction of chemotherapy regimen and terms of intensive phase of treatment.;2 tbl, 1 ex
机译:技术领域本发明涉及医学,即生理学,可用于治疗由结核分枝杆菌(MDR MBT)的多药耐药和高毒性菌株诱导的浸润性肺结核(IPT)。如果确定了结核分枝杆菌的多种耐药性,则在1.5个月内静脉给予氟喹诺酮和异烟肼,以及泼尼松龙25-30 mg的剂量。之后进行强化治疗方案,校正异烟肼的剂量-如果对小浓度的药物产生耐药性,则以15 mg / kg的剂量静脉注射异烟肼,如果对中,高浓度的药物产生耐药性-剂量为20 mg /分两步-静脉注射,每口口服0.3 g,间隔5-6小时,如果确定了分枝杆菌的高毒性,强化治疗方案可延长至8-10个月。效果:本发明的应用使得由于对化疗方案和强化治疗阶段进行了最佳校正,因此提高了耐多药MBT诱导的IPT的治疗效率。2tbl,1 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号